Enrico Mastrobattista

Enrico Mastrobattista obtained his Ph.D. in Advanced Drug Delivery from Utrecht University in 2001 and spent over two years as a Marie Curie postdoctoral fellow in the MRC-Laboratory of Molecular Biology in Cambridge (UK). He currently leads a research group that develops biomimetic drug delivery systems for the targeted delivery of therapeutic proteins, peptides and nucleic acids.

His main areas of expertise are drug delivery, pharmaceutical biotechnology and nanobiotechnology with a focus on the intracellular delivery of nucleic acids and genetic vaccines. Prof. Mastrobattista has published over 120 articles in scientific journals, contributed to several book chapters in pharmaceutical biotechnology and holds several patents to his name. A total of 14 PhD students obtained their doctorate under his direct supervision. In addition, he served as the scientific coordinator of IMI COMPACT, a public-private partnership with a total budget of 30M€ in which 132 scientists from industry, SMEs and academia work together to find solutions for the delivery problem of biopharmaceuticals (www.compact-research.org). In 2013 he was awarded the prestigious Galien research price, The Netherlands, for his research on drug delivery (www.galenusprijs.nl). In addition, he is a board member of the Netherlands Society of Gene & Cell Therapy (www.nvgct.nl).